Ginsenoside Rg1 can effectively treat CFS by regulating expression levels of AKT1, VEGFA and EGFR, and interfering with the metabolism of Taurine and Mannose 6-phosphate. This evidence concerns the gene EGFR and myalgic encephalomeyelitis/chronic fatigue syndrome.